Short-term Outcomes of High Tibial Osteotomy Using a Plate Versus a Plate With an Interbody Fusion Cage in Adolescent Tibia Vara : a Comparative Study

February 3, 2026 updated by: Atef Ahmed Hafez, Sohag University
Tibia vara is a progressive angular deformity of the lower limb centered at the proximal tibial physis, producing a characteristic bowing of the leg. The condition is believed to result from an abnormal distribution of biomechanical stresses combined with an underlying genetic predisposition. (1) Excessive mechanical loading on the medial portion of the proximal tibial growth plate leads to asymmetric physeal activity, ultimately causing a pathologic varus deformity of the tibia.(²)

Study Overview

Status

Active, not recruiting

Detailed Description

The adolescent tibia vara may affect one or both limbs and is typically identified during or shortly before the pubertal growth spurt. (1) It is more frequently reported among individuals of African descent and those with a body mass index (BMI) greater than 40. (2) The increased body weight in these patients accentuates compressive forces on the posteromedial aspect of the proximal tibial physis,(3) resulting in localized inhibition of growth according to the Heuter-Volkmann principle, and leading to progressive varus deformity.(4) In many cases, associated deformities may also be observed at the distal tibia or femur, presenting as either varus or valgus alignment abnormalities.(5) Given the mechanical and structural nature of this deformity, corrective high tibial osteotomy (HTO) remains the cornerstone of surgical management in adolescent tibia vara. Modern fixation methods particularly the use of plate fixation versus plate combined with interbody fusion cage are being explored to enhance alignment correction, stability, and long-term outcomes in this challenging age group.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sohag, Egypt
        • Sohag Univesity Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adolescents aged [10-18] years diagnosed with tibia vara.
  • Symptomatic varus deformity centered at the proximal tibia requiring surgical correction.
  • Both sexes included
  • Open or transitional growth plates are suitable for HTO.

Exclusion Criteria:

  • Prior tibial realignment surgery on the same side.
  • Ages below 10 years or above 18 years
  • Active infection, progressive metabolic disorder (e.g., rickets) or skeletal dysplasia, neuromuscular disorder, or systemic inflammatory arthritis.
  • Complex deformities need external fixation as the first-line treatment.
  • Patients with chronic comorbidities.
  • Associated with fractures in the same limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group A: Corrective HTO with plate fixation only.
correction of adolescent tibia vara with high tibial osteotomy using interbody fusion cage
Active Comparator: Group B: Corrective HTO with plate fixation plus an interbody fusion cage.
correction of adolescent tibia vara with high tibial osteotomy using interbody fusion cage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
correction of tibia vara radiologically
Time Frame: 6 months
Change in MPTA from baseline to 6 months, measured on radiographs by two blinded observers.
6 months
correction of tibia vara on radiographs
Time Frame: 6 months
Change in MPTA from baseline to 6 months, measured on radiographs by two blinded observers.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2025

Primary Completion (Actual)

October 6, 2025

Study Completion (Estimated)

October 6, 2026

Study Registration Dates

First Submitted

February 3, 2026

First Submitted That Met QC Criteria

February 3, 2026

First Posted (Actual)

February 10, 2026

Study Record Updates

Last Update Posted (Actual)

February 10, 2026

Last Update Submitted That Met QC Criteria

February 3, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data and related study documents (protocol, CRF, SAP) will be made available upon reasonable request. Data will be accessible starting 6 months after the main results publication and will remain available for at least 5 years. Access will be granted to qualified researchers after approval of a research proposal and completion of a data sharing agreement. Data will be stored in a secure, publicly accessible repository

IPD Sharing Time Frame

6 months anf for 5 years

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tibia Vara in Children

Clinical Trials on high tibial osteotomy using interbody fusion cage

Subscribe